Alnylam Grants Bio-Rad License to Kreutzer-Limmer Patents for the RNA Interference (RNAi) Research Products Market
Alnylam Pharmaceuticals, Inc. announced today that it has granted Bio-Rad a non-exclusive license to provide RNAi research products under the Kreutzer-Limmer patent family. This patent family, owned exclusively by Alnylam, covers small interfering RNAs (siRNAs) and their use to mediate RNAi in mammalian cells.
"Execution of this license agreement with Bio-Rad, a global leader in the life science research community, continues to underscore the value of the Kreutzer-Limmer patent family as a critical component of fundamental intellectual property in the field of RNAi," said Roland Kreutzer, Ph.D., Managing Director of Alnylam Europe AG. "This agreement brings the number of licenses that Alnylam has granted to more than 20, including 13 with research product suppliers. In fact, we believe that over 75 percent of industrial sales of siRNAs for research purposes are currently being made under access to Alnylam's intellectual property."
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Pocket-sized invention revolutionizes ability to detect harmful materials - The low-cost cellphone-based Raman spectrometer system can make identifications of unknown biological molecules within minutes

Scientists synthesized light with new intrinsic chirality to tell mirror molecules apart - Let there be… a new light

Inherited mutation leads to overproduction of EPO

New rapid test: Only a few seconds to the result - "The new measurement method opens up many possible applications where speed and reliability are required"

DNA dominos on a chip - Carriers of genetic information packed together on a biochip like in nature

SIM Scientific Instruments Manufacturer GmbH - Oberhausen, Germany

Single-cell test can reveal precisely how drugs kill cancer cells - New method sees how pharmaceuticals induce cancer cell death and how cancer cells adapt

Many paths are open to neurons born early - The time of birth of neurons determines what they can become
Sun Pharma announces closure of merger deal with Ranbaxy
New Scripps Research Study Solves Structural Mystery of Cellular Protein Transport - Findings Could Open Door to New Therapies for Cystic Fibrosis and Other Diseases

Epigenetics enigma resolved - First structure of enzyme that removes methylation
